{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:06:47Z","timestamp":1771002407163,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.clinbiochem.2018.01.018","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T10:08:32Z","timestamp":1517479712000},"page":"168-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Assessment of biotin interference with qualitative point-of-care hCG test devices"],"prefix":"10.1016","volume":"53","author":[{"given":"Grace R.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Cervinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Nerenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinbiochem.2018.01.018_bb0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejpn.2015.05.008","article-title":"Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone","volume":"19","author":"Tabarki","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2018.01.018_bb0010","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3945\/jn.116.238956","article-title":"Biotin: from nutrition to therapeutics","volume":"147","author":"Mock","year":"2017","journal-title":"J. Nutr."},{"issue":"10","key":"10.1016\/j.clinbiochem.2018.01.018_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2017.84","article-title":"Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics","volume":"19","author":"Strovel","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.clinbiochem.2018.01.018_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2015.11.043","article-title":"Drugs indicated for mitochondrial dysfunction as treatments for acute encephalopathy with onset of febrile convulsive status epileptics","volume":"360","author":"Omata","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.clinbiochem.2018.01.018_bb0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/thy.2015.0664","article-title":"Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses","volume":"26","author":"Barbesino","year":"2016","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.clinbiochem.2018.01.018_bb0030","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1515\/cclm-2016-0628","article-title":"Biotin interference in immunoassays mimicking subclinical Graves' disease and hyperestrogenism: a case series","volume":"55","author":"Batista","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2018.01.018_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/17425255.2016.1136288","article-title":"Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis","volume":"12","author":"Peyro Saint Paul","year":"2016","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.clinbiochem.2018.01.018_bb0040","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0271-5317(88)80112-X","article-title":"Biotin levels in plasma and urine of healthy adults consuming physiological doses of biotin","volume":"8","author":"Clevidence","year":"1988","journal-title":"Nutr. Res."},{"key":"10.1016\/j.clinbiochem.2018.01.018_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cccn.2005.04.011","article-title":"A simple binding assay for the direct determination of biotin in urine","volume":"360","author":"Mishra","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2018.01.018_bb0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1515\/CCLM.2005.010","article-title":"Quantitative automated human chorionic gonadotropin measurement in urine using the Modular Analytics E170 module (Roche)","volume":"43","author":"Ajubi","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2018.01.018_bb0055","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2017.13705","article-title":"Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults","volume":"318","author":"Li","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.01.018_bb0060","first-page":"65","article-title":"Studies on bioavailability of oral biotin doses for humans","volume":"59","author":"Bitsch","year":"1989","journal-title":"Int. J. Vitam. Nutr. Res."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912017311657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912017311657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:52:14Z","timestamp":1757865134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912017311657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":12,"alternative-id":["S0009912017311657"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.01.018","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of biotin interference with qualitative point-of-care hCG test devices","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}